Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 142Osteosarcoma 26Liposarcoma 25Leiomyosarcoma 25Histiocytoma, Malignant Fibrous 19Hemangiosarcoma 18Sarcoma, Synovial 17Neurofibrosarcoma 17Fibrosarcoma 17Rhabdomyosarcoma 16Dendritic Cell Sarcoma, Interdigitating 16Sarcoma, Ewing 13Neuroectodermal Tumors, Primitive, Peripheral 11HIV Infections 11Sarcoma, Kaposi 10Neoplasms 10Neoplasm Metastasis 10Malignant mesenchymal tumor 10Acquired Immunodeficiency Syndrome 10Lymphoma, Large B-Cell, Diffuse 9Dermatofibrosarcoma 9Ovarian Neoplasms 8Lymphoma 8Hemangiopericytoma, Malignant 8Desmoplastic Small Round Cell Tumor 8Sarcoma, Alveolar Soft Part 6Chondrosarcoma, Extraskeletal Myxoid 6Bone Neoplasms 6Chondrosarcoma 5Burkitt Lymphoma 5

Interventions

Oncolytic Virotherapy 2repotrectinib 1pembrolizumab 1pamiparib 1interferon gamma-1b 1cixutumumab 1Vincristine 1Thiotepa 1Temozolomide 1Radiation 1Peripheral Blood Stem Cell Transplantation 1ONC206 1Melphalan 1Interferon-gamma 1Immunotherapy 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Erlotinib Hydrochloride 1Doxorubicin 1Cyclophosphamide 1Busulfan 1Bone Marrow Transplantation 1Antibodies, Monoclonal 1Amifostine 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroectodermal Tumors × Doxorubicin × Sarcoma × Clear all
NCT00001209 2008-03-04

A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
120 enrolled
Sarcoma

Sarcoma, Sarcoma, Ewing, Osteosarcoma, Neuroectodermal Tumors, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡